Process for making macrocyclic oximyl hepatitis c protease inhibitors

作者: Kenneth Engstrom , Deqiang Niu , Guoyou Xu , Ying Sun , Zhe Wang

DOI:

关键词:

摘要: The present invention relates to a process for the preparation of macrocyclic compounds that are useful as hepatitis C virus (HCV) protease inhibitor compounds.

参考文章(33)
Fredrik Wångsell, Design and Synthesis of Serine and Aspartic Protease Inhibitors Institutionen för fysik, kemi och biologi. ,(2006)
Bruno Schoentjes, Virginie Sophie Poncelet, Pierre-Henri Storck, Sophie Coupa, Inhibitors of the interaction between mdm2 and p53 ,(2008)
Joel D. Moore, Zhe Wang, Dong Liu, Deqiang Niu, Guoyou Xu, Yat Sun Or, Yonghua Gai, Ying Sun, Datong Tang, Macrocyclic hepatitis c virus serine protease inhibitors ,(2007)
Datong Tang, Joel D. Moore, Zhe Wang, Yat Sun Or, Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors ,(2007)
Meenakshisunderam Sivakumaran, Divvela Venkata Naga Srinvasa Rao, Gollapalli Venkateswara Rao, Ramesh Dandala, Koilpillai Joseph Prabahar, Process for the preparation of pure Finasteride ,(2005)
Suanne Nakajima, Datong Tang, Ying Sun, Yat Sun Or, Zhe Wang, Zhenwei Miao, Tri-peptide hepatitis C serine protease inhibitors ,(2004)
Ronald C. Griffith, Lillian Lou, Christopher D. Roberts, Uli Schmitz, HCV Anti-viral Agents Annual Reports in Medicinal Chemistry. ,vol. 39, pp. 223- 237 ,(2004) , 10.1016/S0065-7743(04)39018-4
Eric L. Elliott, Joel D. Moore, Zhe Wang, Yat Sun Or, Hydrazide-containing hepatitis c serine protease inhibitors ,(2007)
Ying Sun, Zhe Wang, Yat Sun Or, Oximyl dipeptide hepatitis c protease inhibitors ,(2008)